Home
Portfolio
Strategy
Team
News
Contact
Investor Login
Home
Portfolio
Strategy
Team
News
Contact
IDEAYA Announces Dosing of First Patient of MAT2A Inhibitor IDE397 in Phase 1 Clinical Trial Evaluating MTAP-Deletion Solid Tumors
Read Article
News
2021
2020
Archive
January 10, 2020
Akouos Announces Senior Leadership Team Appointments
January 10, 2020
Crossroads Treatment Centers Teams with Pear Therapeutics to Bring the First Ever Digital Therapy to an Opioid Addiction Treatment Program
January 10, 2020
Impel NeuroPharma Announces Appointment of Adrian Adams as Chairman of the Board of Directors
January 8, 2020
Entrada Therapeutics Announces ENTR-501 for the Treatment of Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE)
January 8, 2020
Vor Biopharma Expands Leadership Team with Chief Legal Officer and Vice President of People
January 7, 2020
Novome Biotechnologies Raises $33 Million Series A Financing and Appoints Blake Wise as Chief Executive Officer
January 7, 2020
Pear Therapeutics Expands Pipeline with Machine Learning, Digital Therapeutics and Digital Biomarker Technologies
« Previous Page
1
…
12
13
14
